The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Benedetti, A. D., Pytel, B. A., & Baglioni, C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.3.658 · Cited by 43
RetractedEpidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Szabo, S. J., Dighe, A. S., Gubler, U., & Murphy, K. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.817 · Cited by 1,005
Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells
Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., & Sinigaglia, F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.825 · Cited by 766
Self-administered Topical 5% Imiquimod Cream for External Anogenital Warts
Edwards, L. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.1.25 · Cited by 559
Immunological Events in Regressing Genital Warts
Coleman, N., Birley, H. D. L., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne, M., Taylor-Robinson, D., & Stanley, M. A. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.6.768 · Cited by 479
Treatment of genital warts with an immune-response modifier (imiquimod)
Beutner, K. R., Spruance, S. L., Hougham, A. J., Fox, T. L., Owens, M. L., & Douglas, J. M. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70243-9 · Cited by 299
Self-citationSuzuki, H., Wang, B., Shivji, G. M., Toto, P., Amerio, P., Sauder, D. N., Tomai, M. A., & Miller, R. L. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00833.x · Cited by 284
Self-citationCytokine induction by the immunomodulators imiquimod and S-27609
Testerman, T. L., Gerster, J. F., Imbertson, L. M., Reiter, M. J., Miller, R. L., Gibson, S. J., Wagner, T. L., & Tomai, M. A. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.3.365 · Cited by 265
Self-citationTyring, S. K., Arany, I., Stanley, M. A., Tomai, M. A., Miller, R. L., Smith, M. H., McDermott, D. J., & Slade, H. B. (1998) · Journal of Infectious Diseases · doi:10.1086/517472 · Cited by 250
Self-citation
Cited by
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522
Recognition of pathogen-associated molecular patterns by TLR family
Akira, S., & Hemmi, H. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00228-6 · Cited by 1,150
Broughton, G., Janis, J. E., & Attinger, C. E. (2006) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000222562.60260.f9 · Cited by 917
Geisse, J., Caro, I., Lindholm, J., Golitz, L., Stampone, P., & Owens, M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.11.066 · Cited by 505
Self-citationIto, T., Amakawa, R., Kaisho, T., Hemmi, H., Tajima, K., Uehira, K., Ozaki, Y., Tomizawa, H., Akira, S., & Fukuhara, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020207 · Cited by 466
Metadata
- Authors
- Miller, R. L., Gerster, J. F., Owens, M. L., Slade, H. B., & Tomai, M. A.
- Venue
- International Journal of Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 1999-01
- Volume
- 21
- Issue
- 1
- Pages
- 1-14
- ISSN
- 0192-0561 (ISSN-L)
- OpenAlex
- W1985299393
- Cited by
- 417
- References
- 24
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug. https://app.cochat.ai/papers/10.1016/s0192-0561(98)00068-x
- The paper
- Miller, R. L., Gerster, J. F., Owens, M. L., Slade, H. B., & Tomai, M. A. (1999). Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug. International Journal of Immunopharmacology. https://doi.org/10.1016/s0192-0561(98)00068-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.